Refine your search
899 results found
Reed Smith LLP | USA | 4 Dec 2023
CPAP MDL Overinflates Plaintiffs’ Claims
Abuse of substantive law as a weapon to force settlement occurs so frequently in Multidistrict Litigation ("MDL"), that we've given it a name - "the…
Pearce IP | Australia, China, European Union, etc. | 13 Nov 2023
BioBlast w/e 10 Nov 23
Bayer announced that the EMA’s Committee for Medicinal Products for Human Use (CHMP) has recommended approval of 8mg Eylea® (aflibercept)…
Pearce IP | USA | 8 Nov 2023
New Approval Alert: FDA approves Eli Lilly’s Zepbound™ (Tirzepatide) for Chronic Weight Management
The FDA approved Eli Lilly’s Zepbound™ (Tirzepatide) as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight…
Pearce IP | European Union, India, United Kingdom, etc. | 6 Nov 2023
BioBlast w/e 03 Nov 23
Merck announced that the US FDA has approved Keytruda® (pembrolizumab) for the treatment of patients with locally advanced unresectable or metastatic…
Bristows | European Union, United Kingdom | 3 Nov 2023
Irides: Weekly patent litigation update
The Irides Weekly Update is our round-up of patent litigation news highlights from around the world. Taking its name from the plural of “iris” - a…
Pearce IP | USA | 26 Oct 2023
Approval Alert: FDA Approves Eli Lilly’s Omvoh® (mirikizumab) to Treat Moderate to Severe UC
Eli Lilly announced that the FDA has approved its Omvoh® (mirikizumab-mrkz) for the treatment of moderately to severely active ulcerative colitis…
Fenwick & West LLP | USA | 19 Oct 2023
2023 Proxy Season Results in Silicon Valley and Large Companies Nationwide
Shareholder activism has been a significant phenomenon among the largest U.S. public companies, with activists of a variety of stripes waging…
Carpmaels & Ransford LLP | European Union | 16 Oct 2023
The proposed new SPC regulations - what are stakeholders saying?
A team at Carpmaels has reviewed the extensive feedback from stakeholders on the new SPC regulations proposed by the European Commission (see here…
Venable LLP | USA | 10 Oct 2023
Venable’s BiologicsHQ Monthly Injection - September 2023
LATEST NEWS October 10, 2023 New FDA Guidance Removes Interchangeability Statement from Product Labels By: Robert S. Schwartz, Ph.D. On…
YMF Law | USA | 1 Oct 2023
$176 Million Jury Verdict Sunk by Patents’ Insufficient Invention Disclosure--Teva v. Eli Lilly & Co
In Teva Pharm. Int’l GmbH v. Eli Lilly & Co., No. 18-cv-12029 (D. Mass. Sep. 26, 2023), the United States District Court for the District of…
